Envirotainer expands capacity to meet future need for temperature-controlled pharma shipping

Envirotainer is stepping up production to meet “incredibly high demand for secure, temperature-controlled units to transport vital medicines around the globe”.

The company said it had “extensively” expanded its production site in Rosersberg, just north of Stockholm, Sweden.

Envirotainer noted that, this year alone, the business will add annual shipping capacity of ~200 million more doses. By the end of 2022, the company will be capable of shipping over one billion vials per year.

The Rosersberg site is the largest in the world in terms of output, Envirotainer said. It’s also been designed to allow further expansion in the future.

The Envirotainer fleet covers more than 2,000 pharmaceutical trade lanes in over 100 countries and 300 airports. Its services help pharma companies meet the strictest requirements in pharmaceutical air freight and include the new Releye RAP and RLP models, which Envirotainer said were the largest and most advanced of their type on the market.

“The demand for our services has been sky-high since the start of the pandemic. The need to safely transport pharmaceuticals while minimising wasted space in precious air cargo has increased dramatically,” said Envirotainer’s head of quality control and production manager Sofie Nordhamren.

“The added capacity will help our customers be more efficient, sustainable, and reduce the likelihood of a temperature deviation to virtually zero. This nearly eliminates the likelihood of valuable product loss.”

Sign In

Lost your password?